Lantus to be discontinued PBS Long-acting insulin Lantus will be discontinued from the Pharmaceutical Benefits Scheme (PBS) as of June 30, 2020.Wednesday, 17 June 2020
PBAC calls for consumer comment on Trulicity PBS The Pharmaceutical Benefits Advisory Committee (PBAC) is calling for consumer comments Dulaglutide (Trulicity) being added to the PBS or reimbursed by GovernmentFriday, 13 September 2019
